For some time, all branches of the military have used a wide range of sensors to provide data for many purposes, including surveillance, reconnoitring, target detection and battle damage assessment. Many nations have also attempted to utilise these sensors for civilian applications, such as crop monitoring, agricultural disease tracking, environmental diagnostics, cartography, ocean temperature profiling, urban planning, and the characterisation of the Ozone Hole above Antarctica. The recent convergence of several important technologies has made possible new, advanced, high performance, sensor based applications relying on the near-simultaneous fusion of data from an ensemble of different types of sensors. The book examines the underlying principles of sensor operation and data fusion, the techniques and technologies that enable the process, including the operation of 'fusion engines'. Fundamental theory and the enabling technologies of data fusion are presented in a systematic and accessible manner. Applications are discussed in the areas of medicine, meteorology, BDA and targeting, transportation, cartography, the environment, agriculture, and manufacturing and process control.

Accumulation on glia is an active pathological element in many neurological disorders. Gliosis produces neuroinflammation through both neurotrophic and inflammatory means, but the exact mechanism through which this happens remain unclear. It is suspected that damage to neurons activates the growth of glial cells. The proposed book focuses on the interaction between neurons and glia to help elucidate the pathophysiology of neuroinflammation in neurological disorders.

This volume explores how the principles and values of pragmatic philosophy serve as orienting perspectives for critical thinking in contemporary psychotherapy and clinical practice. Drawing on the contributions of William James and John Dewey, Neuroscience, Psychotherapy, and Clinical Pragmatism introduces a model of clinical pragmatism emphasizing the individuality of the person, open-ended dialogue, experiential learning, and the practical outcomes of ideas and methods. In a second part, chapters show how recent developments in neuroscience and interpersonal neurobiology deepen our understanding of change and growth in accord with the principles of clinical pragmatism. Finally, the volume reviews paradigms of psychotherapy across the psychodynamic, behavioral, cognitive, and humanistic traditions. Case studies show how the pluralist orientation of clinical pragmatism enlarges concepts of therapeutic action. This text has been written for psychotherapists as well as scholars, educators, and trainees in the fields of psychiatry, clinical psychology, counseling, and social work.

This book provides comprehensive information, both for clinicians and scientists, on the basic mechanisms, clinical features, and therapeutic approaches to epilepsy as an inflammatory disease. Inflammation has been for many years considered as an etiologic player (and a therapeutic target) for a specific group of epilepsies. However, it turns out that this concept underestimated the impact of inflammation in seizure disorders. Many accepted therapies for non-inflammatory epilepsies act in part as an inflammatory drug. The CNS actively responds to acute immune challenges by altering body temperature, stimulating the HPA axis, as well as up- and down-regulating specific sympathetic pathways.

Prominent experimentalists critically review the animal models widely used in developing powerful new therapies for central nervous system diseases. Coverage includes novel uses of animal models of Alzheimer's, Parkinson's, and Huntington's diseases, and studies of aging. Techniques that rely heavily on behavioral analyses, as well as models developed from infusions of neurotoxins and from advances in molecular biology, are thoroughly explicated, as are models developed for more acute neurological conditions, including traumatic brain injury and stroke. Comprehensive and authoritative, Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic offers neuroscientists, pharmacologists, and interested clinicians a unique survey of the most productive animal models of the leading neurological diseases currently employed to develop today's innovative drug therapies.

Freedom of thought is one of the great and venerable notions of Western thought, often celebrated in philosophical texts - and described as a crucial right in American, European, and International Law, and in that of other jurisdictions. What it means more precisely is, however, anything but clear; surprisingly little writing has been devoted to it. In the past, perhaps, there has been little need for such elaboration. As one Supreme Court Justice stressed, "[f]reedom to think is absolute of its own nature" because even "the most tyrannical government is powerless to control the inward workings of the mind." But the rise of brain scanning, cognition enhancement, and other emerging technologies make this question a more pressing one. This volume provides an interdisciplinary exploration of how freedom of thought might function as an ethical principle and as a constitutional or human right. It draws on philosophy, legal analysis, history, and reflections on neuroscience and neurotechnology to explore what respect for freedom of thought (or an individual's cognitive liberty or autonomy) requires.

Common forms of preventable hearing loss are drug and noise-induced hearing loss which are believed to be produced by a similar mechanism. The generation of reactive oxygen species appears to be a common mechanism mediating hearing loss produced by these different sources. As such, a number of laboratories have focused their research towards identifying the sources of ROS production in the cochlea following administration of chemotherapeutic agents or noise exposure. This led to the identification of ROS generating enzymes, such as xanthine oxidases, nitric oxide synthase, and NADPH oxidases which are activated and/or induced during the development of hearing loss. A consequence of these findings was the implementation of antioxidants in preclinical studies for the treatment of hearing loss. These antioxidants have provided different levels of protection in animal and human studies, but none of these have been approved by the US Food and Drug Administration for the treatment of hearing loss. More recently, it was shown that noise-induced hearing loss was associated with recruitment of inflammatory cells and mediators in the cochlea. This finding would suggest that noise could produce injury to the cochlea which stimulates local and/or circulating inflammatory cells. A similar finding was observed in the cochlea following administration of the anticancer drug, cisplatin. In addition, our laboratory and others have provided a plausible mechanism by which noise or chemotherapeutic agents could stimulate the inflammatory response. Surprisingly, this mechanism involves ROS activation of transcription factors linked to inflammatory processes in the cochlea. These studies have led to the use of anti-inflammatory agents for the treatment of hearing loss. Preliminary studies targeting inflammatory cytokines appear especially promising in preclinical studies. A primary goal of this project is to describe our current understanding of the oxidant hypothesis of noise and drug-induced hearing loss and show how this relates to cochlear inflammation. Several different aspects of the cochlear inflammatory process will be discussed in detail, ranging from the sources of inflammatory cells, chemokines, inflammatory cytokines, and cochlea resident immune cells. Molecular pathways leading to activation of the local inflammatory process will be highlighted and treatment options will be discussed. The relevance of certain clinically used anti-inflammatory interventions, such as trans-typmanic steroids will also be discussed. Furthermore, we will examine recent patents focusing on the use of anti-inflammatory agents for the treatment of drug and noise-induced hearing loss.

This book is the result of an international symposium in biological psychology, held in honor of Knut Larsson. This renowned researcher -- in his search for the true meaning of "mind vs. matter" -- became involved in many divergent areas of the field, such as the neurobiology of sexual behavior and sexual differentiation, aspects of functional neuroanatomy, behavioral endocrinology, and psychopharmacology. Through experimentation and much consultation with other area specialists, Larsson observed such phenomena as the adaptation of behavior-determining neuroendocrine events to the physical environment and the hormonal regulation of sexual behavior and differentiation. This tribute to his research presents important features of necessary paradigms for the analysis and study of experimental psychology within the biological perspective.

This book is based on an international symposium titled "Cytochrome oxidase in energy metabolism and Alzheimer's disease," held as a satellite to the 27th meeting of the Society for Neuroscience, New Orleans, 1997. The symposium was dedicated in honor of Dr. Margaret T. T. Wong-Riley because, in our opinion, the cytochrome oxidase histo chemical method introduced by Dr. Wong-Riley in 1979 was the most significant break through to map energy metabolism in the entire brain since the 2-deoxyglucose method introduced by Dr. Louis Sokoloff and colleagues in 1977. Both of these metabolic map ping techniques have made monumental contributions to brain research by allowing an integral view of brain activity. They have also developed into various specialized tech niques, including applications to the human brain. One of these new applications, which is described in detail in this book, is the quantitative cytochrome oxidase cytochemical method used to study Alzheimer's disease. The objective of this book is to describe the role of cytochrome oxidase in neuronal metabolism and Alzheimer's disease. Whether genetic or environmental, the pathogenesis of Alzheimer's disease involves a cascade of multiple intracellular events, eventually re sulting in failure of oxidative energy metabolism. Could impairment of cytochrome oxi dase in energy metabolism initiate the degenerative process? Cytochrome oxidase function and dysfunction are discussed in relationship to neuronal energy metabolism, neurodegen eration, and Alzheimer's disease. The book is made up of 10 chapters, divided into three major parts."

This book illustrates the role of randomness and noise in living organisms. Traditionally, the randomness and noise have been used in understanding signal processing in communications. This book is divided into two sections, the first of which introduces readers to the various types and sources of noise and the constructive role of noise in non-linear dynamics. It also analyses the importance of randomness and noise in a variety of science and engineering applications. In turn, the second section discusses in detail the functional role of noise in biological processes for example, in case of brain function at the level of ion channel, synaptic level and even at cognitive level. These are described in various chapters. One of the challenging issue finding the neuronal correlates of various meditative states is to understand how brain controls various types of noise so as to reach a state of synchronized oscillatory state of the brain corresponding to the state of Samadhi. This is described in details in one chapter called Noise, Coherence and meditation. The concept of noise and the role of randomness in living organism raise lot of controversy for last few decades. This is discussed in a separate chapter. Finally, the epistemic and ontic nature of randomness as discussed in physical science are investigated in the context of living organism.

This book offers students an introduction to human spatial cognition and experience and is designed for graduate and advanced undergraduate students who are interested in the study of maps in the head and the psychology of space. We live in space and space surrounds us. We interact with space all the time, consciously or unconsciously, and make decisions and actions based on our perceptions of that space. Have you ever wondered how some people navigate perfectly using maps in their heads while other people get lost even with a physical map? What do you mean when you say you have a poor "sense of direction"? How do we know where we are? How do we use and represent information about space? This book clarifies that our knowledge and feelings emerge as a consequence of our interactions with the surrounding space, and show that the knowledge and feelings direct, guide, or limit our spatial behavior and experience. Space matters, or more specifically space we perceive matters. Research into spatial cognition and experience, asking fundamental questions about how and why space and spatiality matters to humans, has thus attracted attention. It is no coincidence that the 2014 Nobel Prize in Physiology or Medicine was awarded for research into a positioning system in the brain or "inner GPS" and that spatial information and technology are recognized as an important social infrastructure in recent years. This is the first book aimed at graduate and advanced undergraduate students pursuing this fascinating area of research. The content introduces the reader to the field of spatial cognition and experience with a series of chapters covering theoretical, empirical, and practical issues, including cognitive maps, spatial orientation, spatial ability and thinking, geospatial information, navigation assistance, and environmental aesthetics.

This book focuses on energy metabolism and brain functions related to Cortical Spreading Depression of Leao (CSD), an important issue in brain pathophysiology. The first part of the book offers a comprehensive overview of the history and early research on CSD, and then discusses the recent advances in the technology used to map and monitor brain mitochondrial NADH redox state and other physiological functions during CSD. The chapters explore the connection between CSD and mitochondrial function under hypoxia, Ischemia and various drugs treatment, and provide a resource to scientists researching the development of CSD during various brain pathophysiological conditions. This book is essential to scientists and students working in the field of bioenergetics of the brain and various organs and tissues in the body. The use of this technology is also crucial and applicable in the neuroscience field.

This book provides a comprehensive discussion of the development and evolution of flatfish metamorphosis. The chapters use the tissue model to explain a series of metamorphic events, including eye migration, front bone deformation, dorsal fin elongation and regression, and body depth change, left/right asymmetrical pigmentation, give a hypothesis on the mechanism of eye migration, and the evolutionary origin of left/right eye asymmetry. The book is written by expert who has worked on flatfish metamorphosis over 20 years. It serves as a valuable reference for graduate students and researchers in related fields

Brain, Decision Making, and Mental Health acknowledges that thinking is not a constant phenomenon but varies considerably across cultures. Critical thinking is particularly important in bridging thinking divisions and its applicability across sciences, particularly medical sciences. We see critical thinking as educable and the arts as means to achieve this purpose. We address the multidimensional relationship between thinking and health and related mechanisms. Thinking mainly affects emotion regulation and executive function; in other words, both mental and physical health are related as a function of thoughts. Considering the thinking-feeling-emotion regulation/executive function pathway, it would be reasonable to propose thinking capacities-based interventions to impact emotion regulation and executive function, such as mindfulness and psychotherapy. We review decision-making taking place in integrated and social contexts and discuss the decision-making styles-decision outcomes relation. Finally, artificial thinking and intelligence prepare us for decision-making outside the human mind.

Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics.

This volume explores the latest techniques used to study neurodevelopmental diseases (NDD) that range from molecular aspects to integrated research approaches and brain imaging in living rodents. Chapters in this book cover topics such as protocols to deliver shRNA in vitro and in vivo using lentiviral particles to knock-down specific protein expression; experimental procedures to use recombinant fluorescent probes to visualize endogenous proteins at the mammalian synapse; CRISPR/Cas9 toolkit to assess either gain- or loss-of-gene function in brain organoids; detailed protocols to use in vivo manipulations to correct the behavioral phenotypes in cognitive disorder mouse lines; and experimental approaches to genetically engineer macaque models of NDDs and investigate how genetic predisposition may cause neural and functional alterations. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and practical, Translational Research Methods in Neurodevelopmental Disorders is a valuable resource for all researchers who want to learn more about this important and developing field.

Despite all our highly publicized efforts to improve our schools, the United States is still falling behind. We recently ranked 15th in the world in reading, math, and science. Clearly, more needs to be done. In The Learning Brain, Torkel Klingberg urges us to use the insights of neuroscience to improve the education of our children. The key to improving education lies in understanding how the brain works: that is where learning takes place, after all. The book focuses in particular on "working memory"--our ability to concentrate and to keep relevant information in our head while ignoring distractions (a topic the author covered in The Overflowing Brain). Research shows enormous variation in working memory among children, with some ten-year-olds performing at the level of a fourteen-year old, others at that of a six-year old. More important, children with high working memory have better math and reading skills, while children with poor working memory consistently underperform. Interestingly, teachers tend to perceive children with poor working memory as dreamy or unfocused, not recognizing that these children have a memory problem. But what can we do for these children? For one, we can train working memory. The Learning Brain provides a variety of different techniques and scientific insights that may just teach us how to improve our children's working memory. Klingberg also discusses how stress can impair working memory (skydivers tested just before a jump showed a 30% drop in working memory) and how aerobic exercise can actually modify the brain's nerve cells and improve classroom performance. Torkel Klingberg is one of the world's leading cognitive neuroscientists, but in this book he wears his erudition lightly, writing with simplicity and good humor as he shows us how to give our children the best chance to learn and grow.

The origins of tinnitus and the development of effective treatments to treat tinnitus have puzzled scientists and clinicians for centuries. Now ground breaking research is beginning to unlock its secrets. The Behavioral Neuroscience of Tinnitus provides critical and comprehensive discussions of the most recent developments in behavioral neuroscience research of tinnitus. Each chapter represents the most important contemporary account of the subject, with an emphasis on preclinical and clinical trials for the development of new diagnostics and therapeutics. New and emerging innovative approaches are covered whenever possible. Six topics are discussed in detail in this volume, which provide new insights in the etiology and mechanisms of tinnitus, new biomarkers towards objective and reliable diagnosis of tinnitus, pharmacological approaches towards curing tinnitus, bioengineering advances towards developing effective medical devices, as well as the latest in psychotherapy methods. The reviews in the volume expose researchers and clinicians, both new and experienced, to exciting advancements and state-of-the-art developments from preeminent researchers in the field of tinnitus.

Measured by any criteria, research in chronobiology in general and chronopharmacology in particular has expanded rapidly in recent years. This expansion has been paralleled by an increasing recognition by those outside the field of the relevance and significance of recent developments in chronobiology. Advances in two areas have been chiefly responsible. First, application of the full range of modern techniques in behavioral, neurochemical, and molecular biology have greatly improved our understanding of basic clock mechanisms. In several species the genetic basis of the circadian clock is being progressively delineated. A complete picture of the neurochemical and neuroanatomical structure of the mammalian clock is emerging and the complex pattern of control mechanisms involving endogenous clock mechan isms and photic and nonphotic zeitgebers is being built up as a result of behavioral studies. Secondly, in parallel with these exciting developments in basic science, clinical applications are being convincingly demonstrated in the general fields of pharmacology and medicine as well as in specific areas, e.g., jet lag, shiftwork maladaption syndrome, blindness, and cardiovascular system. It is therefore an opportune time to review progress in the field of chronopharmacology and to introduce some of the exciting developments and prospects to a readership beyond the confines of the chronobiological cognoscenti. This volume is therefore aimed primarily at the pharmacologist - whether basic, applied, or clinical-who is not a specialist in chronobiology."

This book represents a unique and elaborate exposition of the neural organization of language, memory, and spatial perception in a wide variety of species including humans, bees, fish, rodents, and monkeys. The editors have united the comparative approach with its emphasis on evolutionary determinants of behavior, the neurobiological approach with its emphasis on the neural determinants of behavior, and the cognitive approach with its emphasis on understanding higher-order mental functions. The combination of these three approaches provides an unusual look at the neurobiology of comparative cognition, and should stimulate increased investigations in this field and related disciplines.

This book represents a unique and elaborate exposition of the neural organization of language, memory, and spatial perception in a wide variety of species including humans, bees, fish, rodents, and monkeys. The editors have united the comparative approach with its emphasis on evolutionary determinants of behavior, the neurobiological approach with its emphasis on the neural determinants of behavior, and the cognitive approach with its emphasis on understanding higher-order mental functions. The combination of these three approaches provides an unusual look at the neurobiology of comparative cognition, and should stimulate increased investigations in this field and related disciplines.

Phenotyping of Human iPSC-derived Neurons: Patient-Driven Research examines the steps in a preclinical pipeline that utilizes iPSC-derived neuronal technology to better understand neurological disorders and identify novel therapeutics, also providing considerations and best practices. By presenting example projects that identify phenotypes and mechanisms relevant to autism spectrum disorder and epilepsy, this book allows readers to understand what considerations are important to assess at the start of project design. Sections address reproducibility issues and advances in technology at each stage of the pipeline and provide suggestions for improvement. From patient sample collection and proper controls to neuronal differentiation, phenotyping, screening, and considerations for moving to the clinic, these detailed descriptions of each stage of the pipeline will help everyone, regardless of stage in the pipeline. In recent years, drug discovery in the neurosciences has struggled to identify novel therapeutics for patients with varying indications, including epilepsy, chronic pain, and psychosis. Current treatment options for such patients are decades old and offer little relief with many side effects. One explanation for this lull in novel therapeutics is a lack of novel target identification for neurological disorders (and target identification requires exemplar preclinical data). To improve on the preclinical work that often relies on rodent modeling, the field has begun utilizing patient-derived induced pluripotent stem cells (iPSCs) to differentiate neurons in vitro for preclinical characterization of neurological disease and target identification.

The CTBN volume Therapeutic Applications of Dopamine D3 Receptor Function reviews the state of the knowledge on the dopamine D3 receptor and its role in human behavior and disease (i.e.: neuropsychiatric illnesses including schizophrenia, mood disorders, Parkinson's disease, restless legs syndrome, addictions and substance use disorders). The volume is written by leading experts across multidisciplinary areas (imaging, biobehavioral testing and clinical trials, preclinical models / molecular pharmacology) converging on the therapeutic implications / potential of the D3 receptor.The D3 dopamine receptor is a member of the D2-like family of G protein-coupled receptors. It was cloned and characterized almost 25 years ago. A key feature of the D3 dopamine receptor system, which has attracted considerable attention, is its anatomical localization remarkably restricted to the limbic circuitry. This has spurred the hypothesis that D3 involvement could contribute to the pathophysiology of neuropsychiatric disorders (or to some features of neuropsychiatric disorders), including but not limited to psychosis, addictions and substance abuse, mood and movement disorders.

Attainment and Executive Functioning in the Early Years combines knowledge and understanding from research with operational skills from practice in the early years. It presents the development of a sense of self which occurs between birth and five years, the effect of adverse childhood experiences, and the link to executive functioning in adulthood. The book supports the development of expertise which can be applied to enhance inclusive pedagogy, to nurture attainment and to contribute to life-long learning. It explores practice approaches which support children to gain a sense of self, to recognise the needs of others and to achieve fulfilment by operating with purpose. Research is accessed to gain knowledge and understanding of the complex processes which result in a demonstration of executive functioning in childhood. Attainment and Executive Functioning in the Early Years will be of great interest to academics, researchers and post-graduate students in the fields of early years' care, and education. It will also appeal to those working within children's services.

This volume provides a comprehensive overview of recent advances in targeting glutamate signaling for the treatment of major psychiatric and neurological disorders. It draws on the latest findings in glutamate neurobiology and offers valuable insights into the application of translational principles in neuroscience drug discovery and development. In each chapter, glutamate as a neurotransmitter, its receptors and transporters, and their interplay with other neurotransmitters and neurotrophic factors, are discussed in the context of a specific, highly prevalent and disabling CNS disease. Most recent and detailed information is provided on Ischemic Stroke, Chronic Stress, Major Depressive Disorder, Bipolar Disorder, Autism Spectrum Disorders (ASD), Posttraumatic Stress Disorder (PTSD), Alzheimer's Dementia, Schizophrenia, Impulsive Aggression, Substance Use Disorders (SUD), Amyotrophic Lateral Sclerosis (ALS), Chronic Pain, Multiple Sclerosis, Parkinson's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Migraine, Epilepsy and Anxiety disorders. Moreover, the book includes an extensive overview of glutamatergic treatments already available on the market, and those which are currently in pharmaceutical drug development pipelines. The primary beneficiaries will be neurology and psychiatry specialists and residents, neuroscientists, neuropharmacologists, pharmaceutical industry and clinical research organization professionals, academics, and clinicians working with psychiatric and neurological patients with comorbidities such as cardiologists, pulmonologists, and endocrinologists. This book will also appeal to psychiatry and neurology subspecialists and clinicians working in neuroscience labs seeking an easy-to-understand yet comprehensive overview of contemporary evidence-based clinical insights backed by basic science (preclinical) research evidence. Given its scope, the book is also a unique and indispensable resource for both preclinical and clinical neuroscientists, medical advisors, and clinical research specialists in the pharmaceutical industry. In addition, it will appeal to neuroscience and neuropsychopharmacology students and guide them through the complexities of glutamate involvement in the pathophysiology of the most common debilitating brain diseases with high unmet medical needs.